Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc. (HOWL)

Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
1. 00
+0.02
+1.7347%
Pre Market
$
1. 02
+0.02 +2.3069%
47.61M Market Cap
- P/E Ratio
- Div Yield
426,115 Volume
-1.32 Eps
$ 0.98
Previous Close
Investors:
Add Transaction
Day Range
0.96 1.01
Year Range
0.27 1.83
Want to track HOWL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Werewolf Therapeutics, Inc. (HOWL) Statistics

Valuation metrics

Market Cap 47.61M
Enterprise value 25.62M
Trailing P/E (ttm) -1.33
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 2.27
Price/Book (mrq) 2.92
Enterprise Value/Revenue 1.22
Enterprise Value/EBITDA -1.16

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 501.8K
Average volume (90 days) 706.58K

Price summary

52-Week low 0.27
52-Week high 1.83
Beta -
50-Day moving average 0.96
200-Day moving average 0.67

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.65%
Operating margin -1.22%

Operational effectiveness

Return on assets -1.43%
Return on equity -1.67%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 0.43
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.71
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.45
Total debt (mrq) -
Total Debt/Equity (mrq) 3.09
Current ratio (mrq) 2.91%
Book value per share (mrq) 0.34

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -